Article info

Download PDFPDF

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease
  1. Correspondence to:
    Professor G R Corazza
    Unità di Gastroenterologia, IRCCS Policlinico San Matteo, Università di Pavia, Piazzale Golgi 5, 27100 Pavia, Italy; gr.corazzasmatteo.pv.it
View Full Text

Citation

Di Sabatino A, Ciccocioppo R, Cinque B, et al
Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn’s disease

Publication history

  • Accepted August 5, 2003
  • First published December 18, 2003.
Online issue publication 
December 18, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.